Literature DB >> 19841171

Anergic T cells are metabolically anergic.

Yan Zheng1, Greg M Delgoffe, Christian F Meyer, Waipan Chan, Jonathan D Powell.   

Abstract

Full T cell activation requires TCR engagement (signal 1) in the context of costimulation (signal 2). Costimulation is required for maximal expression of effector cytokines and prevention of T cell anergy. It has become increasingly clear that another major function of costimulation is to up-regulate the metabolic machinery necessary for T cell function. In this report we demonstrate that anergic T cells are metabolically anergic, in that upon full stimulation (signals 1 plus 2) they fail to up-regulate the machinery necessary to support increased metabolism. These findings suggest that one mechanism responsible for the maintenance of T cell anergy is failure to up-regulate the metabolic machinery. Furthermore, we demonstrate that by blocking leucine, glucose, and energy metabolism, T cell activation is mitigated. Additionally, inhibition of these metabolic pathways during T cell activation leads to anergy in Th1-differentiated cells. Overall, our findings extend the role of T cell metabolism in regulating T cell function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841171      PMCID: PMC2884282          DOI: 10.4049/jimmunol.0803510

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness.

Authors:  T L Vanasek; A Khoruts; T Zell; D L Mueller
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 2.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Clonal anergy is maintained independently of T cell proliferation.

Authors:  Sara Colombetti; Fabio Benigni; Veronica Basso; Anna Mondino
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

4.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 5.  Regulation of T lymphocyte metabolism.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

6.  TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27(Kip1).

Authors:  J D Powell; D Bruniquel; R H Schwartz
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

7.  Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.

Authors:  Giovanna Angelini; Stefania Gardella; Massimo Ardy; Maria Rosa Ciriolo; Giuseppe Filomeni; Giovanna Di Trapani; Frank Clarke; Roberto Sitia; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 8.  TOR signaling.

Authors:  Thurl E Harris; John C Lawrence
Journal:  Sci STKE       Date:  2003-12-09

9.  The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.

Authors:  Amy Allen; Yan Zheng; Lawrence Gardner; Meredith Safford; Maureen R Horton; Jonathan D Powell
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Inhibition of amino acid-mTOR signaling by a leucine derivative induces G1 arrest in Jurkat cells.

Authors:  Sujuti Hidayat; Ken-ichi Yoshino; Chiharu Tokunaga; Kenta Hara; Masafumi Matsuo; Kazuyoshi Yonezawa
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

View more
  140 in total

1.  Duration of antigen receptor signaling determines T-cell tolerance or activation.

Authors:  Shoshana D Katzman; William E O'Gorman; Alejandro V Villarino; Eugenio Gallo; Rachel S Friedman; Matthew F Krummel; Garry P Nolan; Abul K Abbas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Metabolic regulation of T cell differentiation and function.

Authors:  Benjamin V Park; Fan Pan
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

3.  Immunometabolism: From basic mechanisms to translation.

Authors:  Liza Makowski; Mehdi Chaib; Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

4.  Fueling memories.

Authors:  Jonathan D Powell; Kristen Pollizzi
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

Review 5.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 6.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Authors:  Jonathan D Powell; Greg M Delgoffe
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

7.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

8.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 9.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

10.  Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells.

Authors:  Frederik C Henrich; Katrin Singer; Kerstin Poller; Luise Bernhardt; Carolin D Strobl; Katharina Limm; Axel P Ritter; Eva Gottfried; Simon Völkl; Benedikt Jacobs; Katrin Peter; Dimitrios Mougiakakos; Katja Dettmer; Peter J Oefner; Anja-Katrin Bosserhoff; Marina P Kreutz; Michael Aigner; Andreas Mackensen
Journal:  Oncoimmunology       Date:  2016-06-10       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.